R&D/Leverage Heightens Investment in Medical and Silicone Mold Man...( LEE'S SUMMIT Mo. Oct. 2 /- R&a...),Health

LEE'S SUMMIT, Mo., Oct. 2 /PRNewswire/ -- R&D/Leverage's enhanced medical and silicone mold manufacturing capabilities - seamlessly integrated under one roof - continue to expand in anticipation of further industry acceleration, according to David Wescoat, the company's Vice President - Engineering.

According to Wescoat, the company's ongoing investment includes the addition of technical and engineering staff, new lean initiatives and quality-control protocols and world-class analysis and process development techniques. The result is a one-stop supplier capability that helps customers create the superior end-products for the world's healthcare and pharma professionals.

"Medical molds, such as those used in high-volume disposable products, are complex, high-cavitation items that require ultra-precise tolerances and uncompromising quality," said Wescoat. "R&D/Leverage, today, offers an unsurpassed suite of services that provide world-class mold manufacturing for this demanding industry.

"Also," he said, "when required we have the capability to assist our customers with processing and molding for short-run capacity issues that arise from time to time.

"R&D/Leverage's suite of mold manufacturing assets includes a diverse group of tool makers, mold designers and project and mechanical engineers - all with access to our validation molding labs, clean rooms and analysis services that mathematically model thermal characteristics, mold deformation and stress, mold-flow and more," Wescoat said.

In addition, the company also now offers mold building for liquid silicone products, where ultra-fine tolerances and the ultimate in flexibility and temperature range integrity are required.

"Our medical mold manufacturing and silicone capabilities represent a significant investment in time and resources," Wescoat said. "Here is an on-campus cross-functional mold manufacturing
'/>"/>